Holubarsch C, Hasenfuss G, Schmidt-Schweda S, Knorr A, Pieske B, Ruf T, Fasol R, Just H
Department of Cardiology, Internal Medicine, University of Freiburg, Germany.
Circulation. 1993 Sep;88(3):1228-37. doi: 10.1161/01.cir.88.3.1228.
The renin-angiotensin system with its renal-humoral and local myocardial components plays an important role in the development and progression of chronic heart failure. Whereas angiotensin receptors have been found in atrial and ventricular myocardium of different species including humans, its influence on myocardial contractility is not yet defined in human failing myocardium and especially in human nonfailing myocardium.
We measured force development of right atrial and right and left ventricular myocardial preparations of patients with a variety of cardiac diseases. To evaluate the physiological effects of angiotensin, experimental temperature and stimulation rates were 37 degrees C and 60 beats per minute, respectively. Angiotensin I and II increased peak developed force in atrial myocardial preparations obtained from patients without heart failure in a concentration-dependent manner. At optimal concentrations, peak developed force is increased from 10.2 +/- 1.8 to 12.3 +/- 1.9 mN/mm2 by angiotensin I (P < .05) and from 15.4 +/- 2.1 to 20.5 +/- 3.3 mN/mm2 by angiotensin II (P < .05). This effect was not influenced by pretreatment with propranolol (10(-6) mol/L) and prazosin (10(-5) mol/L) but was completely blocked by saralasin (10(-6) mol/L). The positive inotropic effect of angiotensin I could be blocked by enalaprilate (10(-5) mol/L). Neither angiotensin I nor angiotensin II had any effect in preparations of the left ventricle from patients with idiopathic dilated cardiomyopathy, mitral valve stenosis, and incompetence or in patients with no significant heart disease. Additionally, no effect could be seen when angiotensin II was applied to right ventricular preparations from infants undergoing reconstructive heart surgery for tetralogy of Fallot.
Angiotensin I and II exert positive inotropic effects via angiotensin receptors in atrial preparations but not in right or left ventricular preparations. Furthermore, the existence of a local myocardial angiotensin converting enzyme with functional importance is shown.
肾素 - 血管紧张素系统及其肾 - 体液和局部心肌成分在慢性心力衰竭的发生和发展中起重要作用。尽管在包括人类在内的不同物种的心房和心室心肌中都发现了血管紧张素受体,但其对心肌收缩力的影响在人类衰竭心肌尤其是人类非衰竭心肌中尚未明确。
我们测量了患有各种心脏病患者的右心房以及右心室和左心室心肌标本的力发展情况。为评估血管紧张素的生理作用,实验温度和刺激频率分别为37℃和每分钟60次搏动。血管紧张素I和II以浓度依赖的方式增加了从无心力衰竭患者获取的心房心肌标本中的峰值发展力。在最佳浓度下,血管紧张素I使峰值发展力从10.2±1.8增加到12.3±1.9 mN/mm²(P <.05),血管紧张素II使其从15.4±2.1增加到20.5±3.3 mN/mm²(P <.05)。这种作用不受普萘洛尔(10⁻⁶ mol/L)和哌唑嗪(10⁻⁵ mol/L)预处理的影响,但被沙拉新(10⁻⁶ mol/L)完全阻断。血管紧张素I的正性肌力作用可被依那普利拉(10⁻⁵ mol/L)阻断。血管紧张素I和血管紧张素II对特发性扩张型心肌病、二尖瓣狭窄和关闭不全患者或无明显心脏病患者的左心室标本均无任何作用。此外,将血管紧张素II应用于接受法洛四联症重建心脏手术的婴儿的右心室标本时也未见任何作用。
血管紧张素I和II通过心房标本中的血管紧张素受体发挥正性肌力作用,但在右心室或左心室标本中则不然。此外,还显示了具有功能重要性的局部心肌血管紧张素转换酶的存在。